CUSIP No. 25056L 103 | 13G |
EXHIBIT A
Joint Filing Agreement
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Design Therapeutics, Inc. a Delaware corporation.
Dated: February 8, 2022
Star Irrevocable Trust #1 dated April 22, 2019 | ||
/s/ Jason Howerton | ||
Jason Howerton, Trustee | ||
/s/ Jason Howerton | ||
Jason Howerton |